GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.1743 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
10.8501 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, XDH |
10.8407 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.4702 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, SLC6A3, SRC, TEK, TYR |
10.2351 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
9.94115 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
8.53353 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
8.51764 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, FLT3, SLC6A3, SRC, TEK, TYR |
8.17433 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
8.10627 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
8.06505 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
8.00628 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
7.63731 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SLC6A3, SRC |
7.56761 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALDH2, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GLO1, HSPA1A, PIM1, PPARA, TYR, XDH |
7.56761 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
7.24978 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC1A1, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
7.22864 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SRC, TEK, XDH |
7.07759 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
7.00066 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.9614 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.9614 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC |
6.79732 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESRRB, F10, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
6.77743 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1 |
6.71476 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, EGFR, GRIK5, INSR, SLC1A1, SLC6A2, SLC6A3, SMAD3 |
6.71476 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
6.71476 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
6.69628 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.69055 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
6.68892 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, TOP2A, XDH |
6.66254 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
6.51077 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, PPARA, SRC, TEK |
6.5004 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, DRD4, EGFR, F10, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, SRC, TEK, XDH |
6.39109 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA |
6.37265 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESRRA, F10, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR |
6.27247 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, BCL2, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
6.26932 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK |
6.23144 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, BCL2, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
6.21029 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK, TOP2A, XDH |
6.11881 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
5.95054 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
5.92446 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8 |
5.92446 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
5.90128 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
5.81511 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.74061 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
5.71178 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, KDR, SLC6A3, SRC |
5.70619 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESRRA, F10, FABP4, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MMP12, MMP2, MMP9, SMAD3, SRC, TEK, XDH |
5.63863 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.6358 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC |
5.58128 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.55405 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F10, INSR, MET, SRC, TEK, XDH |
5.4941 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, PPARA, SRC, TOP2A |
5.3507 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.33265 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
5.29804 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, ALDH2, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD2, DRD3, DRD4, EGFR, HSPA1A, SLC6A3 |
5.29804 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.28879 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, SRC, TYR |
5.28436 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1, SLC6A2, SLC6A3 |
5.22231 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.19503 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FABP3, KDR, SLC6A2, SLC6A3, SRC |
5.18097 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
5.18097 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.15922 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
5.03834 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
5.02395 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
5.00824 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.91766 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.86235 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.84378 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.79865 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.78625 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALDH2, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, SLC6A3, TYR |
4.74739 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.61635 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, SMAD3, SRC, TOP2A |
4.61635 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
4.5837 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, FABP4, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, SLC6A3, SMAD3, SRC, TEK, XDH |
4.56958 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
4.56157 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.43138 |
[BP] GO:0007188 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
4.4137 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK |
4.39032 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CYP19A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, SLC6A3, SMAD3, SRC, TEK, XDH |
4.36929 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.36739 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.3506 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.3506 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.3506 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
4.3506 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, GRM1, GRM5, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
4.3506 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
4.31297 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, F10, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
4.29542 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, TEK |
4.22956 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, EGFR, GRM1, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
4.22849 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.2156 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, SMAD3 |
4.2156 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR |
4.19759 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.18859 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALDH2, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TYR, XDH |
4.17841 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.15885 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
4.12223 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, EGFR, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, INSR, MMP12, MMP9, PPARA, SMAD3, SRC |
4.06434 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, SLC6A3 |
4.05964 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GPR35, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
4.04039 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD17B1, HSD17B2 |
4.02196 |
[BP] GO:0060078 |
None
|
ADORA1, DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
4.00717 |
[BP] GO:0007187 |
None
|
ADORA1, DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
3.97836 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
3.94883 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.94883 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.93969 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.93969 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2 |
3.93743 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, DRD2, DRD4, EGFR, FLT3, GRM1, INSR, KDR, SRC, TEK, XDH |
3.9255 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, DRD2, DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, KDR, SRC, TEK, XDH |
3.91228 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.90357 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.8866 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.82286 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PPARA |
3.82007 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.81957 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.79405 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.78222 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
3.78222 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, DUSP3, EGFR, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, MMP9, PPARA, SRC, TEK, XDH |
3.77333 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.74508 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.73325 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.72073 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.71572 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.71572 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, EGFR, ESRRB, FLT3, GRM1, GRM5, INSR, KDR, MMP9, SRC, TEK, XDH |
3.71572 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.7132 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.681 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.681 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, HCAR2, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, SLC1A1, SLC6A3, SMAD3, SRC, TEK |
3.67461 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, ALDH2, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SLC6A3, SRC, XDH |
3.66356 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.65737 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK |
3.64754 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.62464 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.59114 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.59114 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
3.56653 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
3.56183 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, EGFR, ESR1, FABP4, KDR, MET, MMP12, PPARA, SLC6A3, SMAD3, TEK |
3.55931 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.55931 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.55931 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
3.55931 |
[BP] GO:0007268 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.55519 |
[BP] GO:0098916 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.55519 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK |
3.54402 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIM1, SLC1A1, SLC6A3, SMAD3, SRC, TEK, XDH |
3.54072 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.53816 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, TOP2A |
3.52971 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
3.51826 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD2, DRD3, EGFR, HCAR2, KDR, SRC |
3.50964 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.50352 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.49842 |
[BP] GO:0099536 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.49842 |
[BP] GO:0099537 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.49842 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.49842 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.46129 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.44717 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.44717 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.42762 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, DRD4, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.366 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, INSR, PPARA |
3.35913 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, KDR, MMP9, SRC, TEK, XDH |
3.35843 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, AURKB, BCL2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
3.34992 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
3.3476 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.34471 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
3.34173 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
3.34173 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.34124 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.2913 |
[BP] GO:0006140 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8, INSR, PPARA |
3.28899 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, EGFR, HCAR2, INSR, MMP12, SMAD3, SRC |
3.28895 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.28138 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.27379 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.23154 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, SRC, XDH |
3.23063 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, MMP9, SRC, TEK, XDH |
3.23063 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.22493 |
[BP] GO:0007267 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
3.20538 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.19524 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
3.19514 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
3.19269 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.1845 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.18167 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.18167 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.18167 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, BCL2, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
3.15516 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.15516 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.15516 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
3.13547 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, SRC |
3.13365 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, SRC |
3.13281 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
3.11249 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.10931 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD2, DRD4, EGFR |
3.10931 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.10931 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.06504 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.06504 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
3.05881 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GRM5, IGF1R, INSR, PPARA, SRC, TEK |
3.05774 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR |
3.0556 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
3.03457 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.03457 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, BCL2, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
3.02932 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, GPR35, MMP9 |
2.98553 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.97916 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
2.96823 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, SMAD3, SRC, TEK |
2.9657 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.96082 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DRD2, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
2.94813 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
2.94681 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, PPARA, SRC, TEK |
2.94674 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.93804 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, SRC, TEK, XDH |
2.93684 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.93146 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, BCL2, CSNK2A1, DRD2, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.93064 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, PPARA, SLC6A3, SMAD3, TEK |
2.91723 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, XDH |
2.91215 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.91215 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.89386 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
2.89386 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.88527 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.88527 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.86146 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.85351 |
[BP] GO:0023052 |
None
|
ADORA1, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TEK |
2.82776 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PPARA |
2.82204 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, DRD4, GPR35, MMP9 |
2.81969 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, DRD4, GPR35, MMP9 |
2.81969 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.81632 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SRC |
2.80884 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.79686 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.79686 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.76476 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.72821 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.72806 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
2.72587 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.72517 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.6982 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.6865 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, SRC, TEK |
2.68339 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.65894 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, EGFR, HCAR2 |
2.63677 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.63677 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.63677 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
2.63042 |
[BP] GO:0022898 |
None
|
BCL2, DRD2, DRD3, DRD4, GPR35, GRM5, MMP9 |
2.6156 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, EGFR, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.59483 |
[BP] GO:0034766 |
None
|
DRD2, DRD3, DRD4, GPR35, MMP9 |
2.59394 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, DRD2, DRD3, EGFR, GPR35, GRM1, HCAR2, SLC1A1, SMAD3 |
2.56632 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.56339 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.56339 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.54888 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AURKB, BCL2, DRD2, DRD4, EGFR, ESR1, ESR2, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, MMP9, SMAD3, SRC, TEK, XDH |
2.54888 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, SRC, TEK |
2.52814 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.51781 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
2.51038 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.51038 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.51038 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.51038 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.51038 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.51038 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.51038 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.50942 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PPARA, SLC6A2, SMAD3, SRC, TEK, TOP2A |
2.49526 |
[BP] GO:0034763 |
None
|
DRD2, DRD3, DRD4, GPR35, MMP9 |
2.49291 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC, TOP2A |
2.48758 |
[BP] GO:2001258 |
None
|
DRD2, DRD4, GPR35, MMP9 |
2.4874 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.4874 |
[BP] GO:0032409 |
None
|
BCL2, DRD2, DRD3, DRD4, GPR35, GRM5, MMP9 |
2.4874 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.48245 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.48245 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.48245 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.48245 |
[BP] GO:0040008 |
regulation of growth
|
BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A3, SMAD3 |
2.46601 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.46491 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.46491 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.46491 |
[BP] GO:0007610 |
None
|
BCL2, DRD2, DRD3, DRD4, EGFR, GRM1, GRM5, INSR, PPARA, SLC6A3 |
2.46491 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.45755 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.45755 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.45419 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, F10, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, XDH |
2.45003 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.4472 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.44314 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, EGFR, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.44256 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
2.4396 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, SRC, TEK |
2.4251 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, BCL2, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3 |
2.42285 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.41828 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.41828 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.41443 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, SRC |
2.41004 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.40516 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.40516 |
[BP] GO:0045927 |
positive regulation of growth
|
BCL2, CSNK2A1, DRD2, EGFR, INSR, PIM1, SLC6A3 |
2.3811 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, MMP12, SRC |
2.3811 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, BCL2, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, KDR, MMP9, SRC, TEK, XDH |
2.35675 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SRC |
2.34832 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.34769 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, SRC |
2.34521 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.34096 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, EGFR, GRIK5, HCAR2, MMP12, SRC |
2.33704 |
[BP] GO:0007626 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
2.33611 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, EGFR, ESR1, FLT3, GRM5, IGF1R, INSR, MMP2, SMAD3, SRC |
2.33368 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, SRC, TEK |
2.32354 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.31902 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.31213 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, MMP12, PPARA, SLC1A1, SLC6A2, SLC6A3 |
2.31205 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, DRD4, EGFR, FLT3, GRM1, INSR, SRC |
2.30411 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.29901 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.29611 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP2A6, SLC6A3 |
2.28439 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.28394 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.28394 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28394 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.27311 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.25753 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.25663 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.25653 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.25653 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.25653 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25653 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.25653 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.25653 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.25653 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, SMAD3, SRC, TEK |
2.24768 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.23209 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, DUSP3, EGFR, KDR, SRC, TEK |
2.22883 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.21921 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.21023 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21023 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.20736 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, DUSP3, FABP4, GRM3, GRM8, IGF1R, PPARA, XDH |
2.20385 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, DUSP3, FABP4, GRM3, GRM8, IGF1R, PPARA, XDH |
2.19891 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, GRIK5, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK, TOP2A |
2.18432 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
2.18209 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.18209 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM5, SMAD3 |
2.16973 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, SRC |
2.16973 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, AURKB, BCL2, DRD2, DRD4, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, SMAD3, SRC, TEK, XDH |
2.16973 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.16973 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
BCL2, DRD2, DRD4, GPR35 |
2.16973 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, SRC |
2.1693 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.1693 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.16835 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, EGFR, KDR, SRC, TEK |
2.16054 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.15622 |
[BP] GO:0045934 |
None
|
APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSPA1A, MMP12, PPARA, SMAD3, SRC |
2.14572 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.14147 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, TYR |
2.13513 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GPR35, GRM5, MMP9 |
2.13256 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, SLC6A3 |
2.13256 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.13256 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.13256 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.13256 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.13256 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, DRD4, EGFR, GRIK5, HCAR2, MMP12, SRC |
2.12208 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, DRD2, DRD3, DRD4, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, HCAR2, INSR, SRC |
2.12133 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.11829 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.11829 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.11829 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.11644 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.09418 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.09375 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.0892 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.08732 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.08524 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DRD4, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, SRC |
2.08502 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, GRM5, IGF1R, INSR, MMP2, SRC |
2.07885 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.07307 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, GRM5, IGF1R, INSR, SRC |
2.06357 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.05995 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.03454 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, SMAD3, SRC, XDH |
2.02726 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, DRD2, DRD4, EGFR, FLT3, GRM1, GRM5, INSR, SRC |
2.0226 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.01892 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.01727 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.01727 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.01727 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, ALOX15, AXL, DRD2, DRD3, SLC1A1, SLC6A2, SLC6A3 |
2.01566 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.00977 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, DRD2, DRD3, DRD4, F10, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK |
5.65712 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK |
5.61302 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, AXL, CA2, CA4, CA9, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC, TEK |
5.5549 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, DRD2, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, SLC1A1, SRC, TEK |
5.01993 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TEK |
4.7347 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EGFR, ESR1, F10, FLT3, FUT7, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PIM1, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
3.64815 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, INSR, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC, TEK, TYR |
3.50352 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC |
3.44623 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.32289 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.94495 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.94495 |
[CC] GO:0098794 |
None
|
ADORA1, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.64156 |
[CC] GO:0043235 |
receptor complex
|
EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
2.54016 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.39265 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.26231 |
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.2333 |
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.20736 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.13256 |
[CC] GO:0045121 |
membrane raft
|
EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.09161 |
[CC] GO:0098857 |
membrane microdomain
|
EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.08019 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.4495 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, TYR, XDH |
15.7358 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
12.1427 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.6222 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.4702 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SMAD3, TOP2A, TYR, XDH |
8.93271 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
8.72155 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
8.0195 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.98087 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
7.71894 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
7.56761 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, SMAD3 |
7.52689 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
7.50802 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK, TOP2A, TYR, XDH |
7.44731 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.07759 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SMAD3, TOP2A, TYR, XDH |
6.9686 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.5004 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
6.46857 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.40938 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SLC6A3, SRC, TEK, TOP2A |
6.31779 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
6.13095 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
6.13095 |
[MF] GO:0030594 |
None
|
DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
5.47216 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALDH2, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TYR, XDH |
5.22276 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.16807 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.01061 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.67454 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.4929 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC |
4.31297 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SLC6A3, SMAD3, SRC |
4.11306 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.93219 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.8596 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.81724 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.75199 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.71572 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.71572 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.6651 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.50352 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, SRC, XDH |
3.45982 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.44717 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.40791 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, XDH |
3.34124 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.303 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.06504 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
3.03639 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.97829 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
2.9657 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, DRD2, DRD4, EGFR, ESR1, ESR2, FLT3, GRIK5, IGF1R, KDR, MET, MMP9, SMAD3, TOP2A, TYR, XDH |
2.91215 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91215 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.91215 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.77685 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
2.75513 |
[MF] GO:0016903 |
None
|
AKR1B1, ALDH2, AOX1, XDH |
2.69377 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.64402 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.51038 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.51038 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, SLC6A3, SMAD3 |
2.49335 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.45755 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.45755 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, HSD17B1, PPARA |
2.36307 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, ALDH2, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SLC1A1, SRC, TEK, TOP2A, XDH |
2.33767 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.28394 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.28394 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.21023 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.11829 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.11829 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.08524 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.08524 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.01727 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, HSD17B1, HSD17B2, XDH |
2.00977 |